Cargando…

Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind

Through the application of science to public health practice, National Cancer Control Programmes provide the framework for the development of policies on cancer control, with the ultimate goal of reducing cancer morbidity and mortality, and improving quality of life. In the last decade, a substantia...

Descripción completa

Detalles Bibliográficos
Autores principales: Espina, Carolina, Soerjomataram, Isabelle, Forman, David, Martín-Moreno, Jose M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255794/
https://www.ncbi.nlm.nih.gov/pubmed/30510896
http://dx.doi.org/10.1016/j.jcpo.2018.09.001
_version_ 1783374018364047360
author Espina, Carolina
Soerjomataram, Isabelle
Forman, David
Martín-Moreno, Jose M.
author_facet Espina, Carolina
Soerjomataram, Isabelle
Forman, David
Martín-Moreno, Jose M.
author_sort Espina, Carolina
collection PubMed
description Through the application of science to public health practice, National Cancer Control Programmes provide the framework for the development of policies on cancer control, with the ultimate goal of reducing cancer morbidity and mortality, and improving quality of life. In the last decade, a substantial number of Member States in the European Union (EU) have formulated and/or updated their National Cancer Control Programmes, Plans or Strategies including primary prevention (health promotion and environmental protection), secondary prevention (screening and early detection), integrated care and organization of services, and palliative care as main elements. Although tobacco control and population-based screening policies are examples of best practices that are gradually being implemented in most of the EU countries, there are still large regional differences in cancer burden arising from the wide variety of social determinants and other epidemiological factors, along with gaps in the policy and practical articulation of cancer control within the health systems. On the other hand, few quantitative assessments are available with regard to evaluating the success or failure of the implementation of these programmes, especially in terms of reducing cancer incidence or mortality. An EU framework to better assess of the effectiveness of cancer prevention policies and the factors triggering shortfall in best practices implementation seems imperative.
format Online
Article
Text
id pubmed-6255794
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Ltd
record_format MEDLINE/PubMed
spelling pubmed-62557942018-12-01 Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind Espina, Carolina Soerjomataram, Isabelle Forman, David Martín-Moreno, Jose M. J Cancer Policy Article Through the application of science to public health practice, National Cancer Control Programmes provide the framework for the development of policies on cancer control, with the ultimate goal of reducing cancer morbidity and mortality, and improving quality of life. In the last decade, a substantial number of Member States in the European Union (EU) have formulated and/or updated their National Cancer Control Programmes, Plans or Strategies including primary prevention (health promotion and environmental protection), secondary prevention (screening and early detection), integrated care and organization of services, and palliative care as main elements. Although tobacco control and population-based screening policies are examples of best practices that are gradually being implemented in most of the EU countries, there are still large regional differences in cancer burden arising from the wide variety of social determinants and other epidemiological factors, along with gaps in the policy and practical articulation of cancer control within the health systems. On the other hand, few quantitative assessments are available with regard to evaluating the success or failure of the implementation of these programmes, especially in terms of reducing cancer incidence or mortality. An EU framework to better assess of the effectiveness of cancer prevention policies and the factors triggering shortfall in best practices implementation seems imperative. Elsevier Ltd 2018-12 /pmc/articles/PMC6255794/ /pubmed/30510896 http://dx.doi.org/10.1016/j.jcpo.2018.09.001 Text en © 2018 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Article
Espina, Carolina
Soerjomataram, Isabelle
Forman, David
Martín-Moreno, Jose M.
Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind
title Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind
title_full Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind
title_fullStr Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind
title_full_unstemmed Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind
title_short Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind
title_sort cancer prevention policy in the eu: best practices are now well recognised; no reason for countries to lag behind
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255794/
https://www.ncbi.nlm.nih.gov/pubmed/30510896
http://dx.doi.org/10.1016/j.jcpo.2018.09.001
work_keys_str_mv AT espinacarolina cancerpreventionpolicyintheeubestpracticesarenowwellrecognisednoreasonforcountriestolagbehind
AT soerjomataramisabelle cancerpreventionpolicyintheeubestpracticesarenowwellrecognisednoreasonforcountriestolagbehind
AT formandavid cancerpreventionpolicyintheeubestpracticesarenowwellrecognisednoreasonforcountriestolagbehind
AT martinmorenojosem cancerpreventionpolicyintheeubestpracticesarenowwellrecognisednoreasonforcountriestolagbehind